Literature DB >> 22661569

Spinal muscular atrophy: manifestations and management.

Addisu Mesfin1, Paul D Sponseller, Arabella I Leet.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by a homozygous deletion in the SMN1 gene and is manifested by loss of the anterior horn cells of the spinal cord. Classifications of the disorder are based on age of onset and the patient's level of function. Scoliosis and hip subluxation or dislocation are two musculoskeletal manifestations associated with SMA. Severity of scoliosis correlates with age at presentation. Bracing has been unsuccessful in halting curve progression and may interfere with respiratory effort. Early onset scoliosis associated with SMA has been successfully treated with growing rod constructs, and posterior spinal fusion can be used in older children. Hip subluxations and dislocations are best treated nonsurgically if the patient reports no pain because a high rate of recurrent dislocation has been reported with surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661569     DOI: 10.5435/JAAOS-20-06-393

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  6 in total

1.  The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy type II patients.

Authors:  Shih-Hsiang Chou; Gau-Tyan Lin; Po-Chih Shen; Yi-Jing Lue; Cheng-Chang Lu; Yin-Chun Tien; Yen-Mou Lu
Journal:  Eur Spine J       Date:  2016-11-02       Impact factor: 3.134

Review 2.  The effect of scoliosis surgery on pulmonary function in spinal muscular atrophy patients: review of the literature and a meta-analysis.

Authors:  Maria Angeli; Kalliopi Alpantaki; Nikolaos Pandis; Christos Koutserimpas; Alexander Hadjipavlou
Journal:  Eur Spine J       Date:  2022-06-04       Impact factor: 2.721

3.  Effects of ATLAS 2030 gait exoskeleton on strength and range of motion in children with spinal muscular atrophy II: a case series.

Authors:  C Cumplido-Trasmonte; J Ramos-Rojas; E Delgado-Castillejo; E Garcés-Castellote; G Puyuelo-Quintana; M A Destarac-Eguizabal; E Barquín-Santos; A Plaza-Flores; M Hernández-Melero; A Gutiérrez-Ayala; M Martínez-Moreno; E García-Armada
Journal:  J Neuroeng Rehabil       Date:  2022-07-19       Impact factor: 5.208

4.  Healthcare Utilization, Costs of Care, and Mortality Among Psatients With Spinal Muscular Atrophy.

Authors:  Hiangkiat Tan; Tao Gu; Er Chen; Rajeshwari Punekar; Perry B Shieh
Journal:  J Health Econ Outcomes Res       Date:  2019-12-02

5.  Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment.

Authors:  Alisha Monnette; Er Chen; Dongzhe Hong; Alessandra Bazzano; Stacy Dixon; W David Arnold; Lizheng Shi
Journal:  Orphanet J Rare Dis       Date:  2021-01-20       Impact factor: 4.123

6.  Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis.

Authors:  Josep Darbà; Alicia Marsà
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.